# IGF-1, Sarcopenia and Mortality: a Cohort Study in Patient With Cognitive Impairment

> **NCT02139410** · — · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 589 (actual)

## Conditions studied

- Cognitive Impairment
- Insulin-like Growth Factor 1

## Interventions

- **PROCEDURE:** IGF-1 serum value

## Key facts

- **NCT ID:** NCT02139410
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-09
- **Final completion:** 2013-11
- **Target enrollment:** 589 (ACTUAL)
- **Last updated:** 2014-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139410, "IGF-1, Sarcopenia and Mortality: a Cohort Study in Patient With Cognitive Impairment". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02139410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
